111 related articles for article (PubMed ID: 17549409)
1. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
[TBL] [Abstract][Full Text] [Related]
2. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
3. Protein expression of the chemokine, CCL28, in human colorectal cancer.
Dimberg J; Hugander A; Wågsäter D
Int J Oncol; 2006 Feb; 28(2):315-9. PubMed ID: 16391784
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-17 in human colorectal cancer.
Wägsäter D; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2006; 26(6B):4213-6. PubMed ID: 17201135
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in human colorectal carcinoma.
Baier PK; Eggstein S; Wolff-Vorbeck G; Baumgartner U; Hopt UT
Anticancer Res; 2005; 25(5):3581-4. PubMed ID: 16101183
[TBL] [Abstract][Full Text] [Related]
9. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
10. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas.
Wågsäter D; Dimberg J
Anticancer Res; 2004; 24(6):3711-4. PubMed ID: 15736401
[TBL] [Abstract][Full Text] [Related]
12. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
13. CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Zineh I; Aquilante CL; Langaee TY; Beitelshees AL; Arant CB; Wessel TR; Schofield RS
Cytokine; 2006 Mar; 33(5):258-63. PubMed ID: 16567110
[TBL] [Abstract][Full Text] [Related]
14. Differential CXC receptor expression in colorectal carcinomas.
Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
[TBL] [Abstract][Full Text] [Related]
15. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.
Dimberg J; Hugander A; Sirsjo A
Int J Mol Med; 2001 Jun; 7(6):597-601. PubMed ID: 11351271
[TBL] [Abstract][Full Text] [Related]
17. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.
Antonacopoulou AG; Palli M; Marousi S; Dimitrakopoulos FI; Kyriakopoulou U; Tsamandas AC; Scopa CD; Papavassiliou AG; Kalofonos HP
Mol Carcinog; 2010 Jul; 49(7):693-9. PubMed ID: 20564346
[TBL] [Abstract][Full Text] [Related]
18. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Olsen T; Husebekk A; Vonen B; Florholmen J
Cancer Immunol Immunother; 2007 Dec; 56(12):1993-2001. PubMed ID: 17579859
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCL16 in human rectal cancer.
Wågsäter D; Hugander A; Dimberg J
Int J Mol Med; 2004 Jul; 14(1):65-9. PubMed ID: 15202017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
